Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease.

Kogame N, Takahashi K, Tomaniak M, Chichareon P, Modolo R, Chang CC, Komiyama H, Katagiri Y, Asano T, Stables R, Fath-Ordoubadi F, Walsh S, Sabaté M, Davies JE, Piek JJ, van Geuns RJ, Reiber JHC, Banning AP, Escaned J, Farooq V, Serruys PW, Onuma Y.

JACC Cardiovasc Interv. 2019 Oct 28;12(20):2064-2075. doi: 10.1016/j.jcin.2019.08.009. Epub 2019 Sep 25.

PMID:
31563682
2.

Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study.

Chichareon P, Modolo R, van Klaveren D, Takahashi K, Kogame N, Chang CC, Katagiri Y, Tomaniak M, Asano T, Spitzer E, Buszman P, Prokopczuk J, Fath-Ordoubadi F, Buysschaert I, Anderson R, Oldroyd KG, Merkely B, Garg S, Wykrzykowska JJ, Piek JJ, Jüni P, Hamm C, Steg PG, Valgimigli M, Vranckx P, Windecker S, Onuma Y, Serruys PW.

Int J Cardiol. 2019 Jul 1;286:43-50. doi: 10.1016/j.ijcard.2019.02.043. Epub 2019 Feb 20.

PMID:
30846254
3.

Development and validation of a novel risk score for primary percutaneous coronary intervention for ST elevation myocardial infarction.

Andrews M, Iqbal J, Wall JJ, Teare D, El-Omar M, Fath-Ordoubadi F, Gunn J.

Cardiovasc Revasc Med. 2018 Dec 27. pii: S1553-8389(18)30623-7. doi: 10.1016/j.carrev.2018.12.020. [Epub ahead of print]

PMID:
30773426
4.

A Large, Refractory Nosocomial Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Escherichia coli Demonstrates Carbapenemase Gene Outbreaks Involving Sink Sites Require Novel Approaches to Infection Control.

Decraene V, Phan HTT, George R, Wyllie DH, Akinremi O, Aiken Z, Cleary P, Dodgson A, Pankhurst L, Crook DW, Lenney C, Walker AS, Woodford N, Sebra R, Fath-Ordoubadi F, Mathers AJ, Seale AC, Guiver M, McEwan A, Watts V, Welfare W, Stoesser N, Cawthorne J; TRACE Investigators’ Group.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01689-18. doi: 10.1128/AAC.01689-18. Print 2018 Dec.

5.

Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial.

Abizaid A, Kedev S, Kedhi E, Talwar S, Erglis A, Hlinomaz O, Masotti M, Fath-Ordoubadi F, Lemos PA, Milewski K, Botelho R, Costa R, Bangalore S.

EuroIntervention. 2018 Dec 7;14(11):e1207-e1214. doi: 10.4244/EIJ-D-18-00762.

6.

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.

Escaned J, Collet C, Ryan N, De Maria GL, Walsh S, Sabate M, Davies J, Lesiak M, Moreno R, Cruz-Gonzalez I, Hoole SP, Ej West N, Piek JJ, Zaman A, Fath-Ordoubadi F, Stables RH, Appleby C, van Mieghem N, van Geuns RJ, Uren N, Zueco J, Buszman P, Iñiguez A, Goicolea J, Hildick-Smith D, Ochala A, Dudek D, Hanratty C, Cavalcante R, Kappetein AP, Taggart DP, van Es GA, Morel MA, de Vries T, Onuma Y, Farooq V, Serruys PW, Banning AP.

Eur Heart J. 2017 Nov 7;38(42):3124-3134. doi: 10.1093/eurheartj/ehx512. Erratum in: Eur Heart J. 2018 May 7;39(18):1619.

7.

Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients.

Danzi GB, Piccolo R, Chevalier B, Urban P, Fath-Ordoubadi F, Carrie D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Goicolea Ruigomez J, Sagic D, Laanmets P, Strupp G, West N; Nobori 2 Investigators.

Heart. 2017 Jan 15;103(2):111-116. doi: 10.1136/heartjnl-2016-309283. Epub 2016 Aug 10.

PMID:
27511446
8.

Forward and back aspiration during ST-elevation myocardial infarction: a feasibility study.

Farooq V, Serruys PW, Mustafa AH, Mamas MA, Malik N, Alhous HA, El-Omar M, Hendry C, Rana DN, Shelton D, Wright PK, Narine N, Clarke B, Keavney B, Fath-Ordoubadi F, Fraser DG.

EuroIntervention. 2016 Apr 8;11(14):e1639-48. doi: 10.4244/EIJV11I14A315.

9.

Neoatherosclerosis, plaque rupture and very late stent thrombosis of a first generation drug eluting stent treated with aspiration thrombectomy and newer generation drug eluting stent implantation.

Mustafa A, Daghem S, Farooq V, Fath-Ordoubadi F, Clarke B.

Int J Cardiol. 2015 Dec 15;201:648-9. doi: 10.1016/j.ijcard.2014.12.118. Epub 2014 Dec 30. No abstract available.

PMID:
26344489
10.

Prevalence and Impact of Co-morbidity Burden as Defined by the Charlson Co-morbidity Index on 30-Day and 1- and 5-Year Outcomes After Coronary Stent Implantation (from the Nobori-2 Study).

Mamas MA, Fath-Ordoubadi F, Danzi GB, Spaepen E, Kwok CS, Buchan I, Peek N, de Belder MA, Ludman PF, Paunovic D, Urban P.

Am J Cardiol. 2015 Aug 1;116(3):364-71. doi: 10.1016/j.amjcard.2015.04.047. Epub 2015 May 8.

PMID:
26037294
11.

Serial optical coherence tomography of drug-eluting stent in-stent restenosis treated with the Absorb bioresorbable scaffold: an effective treatment?

Farooq V, Mamas MA, Fraser DG, El-Omar M, Clarke B, Fath-Ordoubadi F.

EuroIntervention. 2015 Mar 22;10(11):e1. doi: 10.4244/EIJV10I11A224. No abstract available.

12.

Lessons from acute and late scaffold failures in the ABSORB EXTEND trial: have we really learned them all?

Farooq V, Fraser DG, El-Omar M, Mamas MA, Clarke B, Fath-Ordoubadi F.

EuroIntervention. 2014 Aug;10(4):419-23. doi: 10.4244/EIJV10I4A73. No abstract available.

13.

Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study.

Fath-Ordoubadi F, Spaepen E, El-Omar M, Fraser DG, Khan MA, Neyses L, Danzi GB, Roguin A, Paunovic D, Mamas MA.

PLoS One. 2014 Feb 14;9(2):e88577. doi: 10.1371/journal.pone.0088577. eCollection 2014.

14.

Minimising radial injury: prevention is better than cure.

Mamas MA, Fraser DG, Ratib K, Fath-Ordoubadi F, El-Omar M, Nolan J, Neyses L.

EuroIntervention. 2014 Nov;10(7):824-32. doi: 10.4244/EIJV10I7A142. Review.

15.

Transradial intervention via large-bore guide catheters: a study of coronary bifurcation disease treatment using the crush technique.

Williams PD, Eichhöfer J, Mamas MA, Arnous S, Fath-Ordoubadi F, Fraser D.

J Invasive Cardiol. 2013 Sep;25(9):455-9.

16.

Serum sphingolipids level as a novel potential marker for early detection of human myocardial ischaemic injury.

Egom EE, Mamas MA, Chacko S, Stringer SE, Charlton-Menys V, El-Omar M, Chirico D, Clarke B, Neyses L, Cruickshank JK, Lei M, Fath-Ordoubadi F.

Front Physiol. 2013 Jun 13;4:130. doi: 10.3389/fphys.2013.00130. eCollection 2013.

17.

Percutaneous intervention on anomalous circumflex coronary arteries--a single centre experience.

Morgan KP, Morris GM, Al-Najjar Y, Clarke B, Fath-Ordoubadi F, Fraser D, Mahadevan V, Mamas M, El-Omar MM.

Cardiovasc Revasc Med. 2012 Nov-Dec;13(6):335-40. doi: 10.1016/j.carrev.2012.08.004. Epub 2012 Sep 18.

PMID:
22995198
18.

Nurses' role in the acute management of patients with non-ST-segment elevation acute coronary syndromes: an integrative review.

Tierney S, Cook G, Mamas M, Fath-Ordoubadi F, Iles-Smith H, Deaton C.

Eur J Cardiovasc Nurs. 2013 Jun;12(3):293-301. doi: 10.1177/1474515112451555. Epub 2012 Jun 29. Review.

PMID:
22752081
19.

Emergency percutaneous coronary intervention to a rare coronary anomaly.

Hendry C, Fath-Ordoubadi F.

J Cardiol Cases. 2012 Jun 27;6(2):e49-e50. doi: 10.1016/j.jccase.2012.04.009. eCollection 2012 Aug.

20.

Gender impact on prognosis of acute coronary syndrome patients treated with drug-eluting stents.

Fath-Ordoubadi F, Barac Y, Abergel E, Danzi GB, Kerner A, Nikolsky E, Halabi M, Mamas M, El-Omar M, Fraser D, Roguin A.

Am J Cardiol. 2012 Sep 1;110(5):636-42. doi: 10.1016/j.amjcard.2012.04.039. Epub 2012 May 30.

PMID:
22651877
21.

Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience.

Hendry C, Fraser D, Eichhofer J, Mamas MA, Fath-Ordoubadi F, El-Omar M, Williams P.

EuroIntervention. 2012 May 15;8(1):79-86. doi: 10.4244/EIJV8I1A13.

22.

Use of the Sideguard (Cappella) stent in bifurcation lesions: a real-world experience.

Mamas MA, Farooq V, Latib A, Sastry S, D'Souza S, Williams P, Wiper A, Neyses L, El-Omar M, Fraser DG, Fath-Ordoubadi F.

EuroIntervention. 2012 Feb;7(10):1170-80. doi: 10.4244/EIJV7I10A188.

23.

Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study.

Danzi GB, Chevalier B, Urban P, Fath-Ordoubadi F, Carrie D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Ruigomez JG, Sagic D, Laanmets P, Strupp G, West N, Paunovic D; NOBORI 2 Investigators.

EuroIntervention. 2012 May 15;8(1):109-16. doi: 10.4244/EIJV8I1A17.

24.

Influence of access site selection on PCI-related adverse events in patients with STEMI: meta-analysis of randomised controlled trials.

Mamas MA, Ratib K, Routledge H, Fath-Ordoubadi F, Neyses L, Louvard Y, Fraser DG, Nolan J.

Heart. 2012 Feb;98(4):303-11. doi: 10.1136/heartjnl-2011-300558. Epub 2011 Dec 6. Review.

PMID:
22147900
25.

Longitudinal stent deformation: a retrospective analysis of frequency and mechanisms.

Williams PD, Mamas MA, Morgan KP, El-Omar M, Clarke B, Bainbridge A, Fath-Ordoubadi F, Fraser DG.

EuroIntervention. 2012 Jun 20;8(2):267-74. doi: 10.4244/EIJV8I2A41.

26.

Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury.

Egom EE, Mohamed TM, Mamas MA, Shi Y, Liu W, Chirico D, Stringer SE, Ke Y, Shaheen M, Wang T, Chacko S, Wang X, Solaro RJ, Fath-Ordoubadi F, Cartwright EJ, Lei M.

Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1487-95. doi: 10.1152/ajpheart.01003.2010. Epub 2011 Jun 24.

27.

Telescoping catheter technique: looking towards the kidneys.

Mamas MA, Fath-Ordoubadi F, Fraser DG.

Cardiovasc Revasc Med. 2011 Mar-Apr;12(2):123-8. doi: 10.1016/j.carrev.2009.09.004. Epub 2010 Oct 20.

PMID:
21421191
28.

Late outcomes of drug eluting and bare metal stents in saphenous vein graft percutaneous coronary intervention.

Nair S, Fath-Ordoubadi F, Clarke B, El-Omar M, Foley J, Fraser DG, Mahadevan VS, Neyses L, Khattar RS, Mamas MA.

EuroIntervention. 2011 Mar;6(8):985-91. doi: 10.4244/EIJV6I8A170.

PMID:
21330247
29.

A comparison of drug-eluting stents versus bare metal stents in saphenous vein graft PCI outcomes: a meta-analysis.

Mamas MA, Foley J, Nair S, Wiper A, Clarke B, El-Omar M, Fraser DG, Khattar R, Neyses L, Fath-Ordoubadi F.

J Interv Cardiol. 2011 Apr;24(2):172-80. doi: 10.1111/j.1540-8183.2010.00620.x. Epub 2011 Jan 31.

PMID:
21281356
30.

The use of a guide catheter extension system as an aid during transradial percutaneous coronary intervention of coronary artery bypass grafts.

Farooq V, Mamas MA, Fath-Ordoubadi F, Fraser DG.

Catheter Cardiovasc Interv. 2011 Nov 15;78(6):847-63. doi: 10.1002/ccd.22942. Epub 2011 Jun 7.

PMID:
21234926
31.

Drug eluting stents for the treatment of bare metal in-stent restenosis: long-term outcomes in real world practice.

Appleby CE, Khattar RS, Morgan K, Clarke B, Curzen N, Neyses L, Fath-Ordoubadi F.

EuroIntervention. 2011 Jan;6(6):748-53. doi: 10.4244/EIJV6I6A127.

PMID:
21205600
32.

Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis.

D'Souza SP, Mamas MA, Fraser DG, Fath-Ordoubadi F.

Eur Heart J. 2011 Apr;32(8):972-82. doi: 10.1093/eurheartj/ehq398. Epub 2010 Oct 28. Review.

PMID:
21036776
33.

A meta-analysis of glucose-insulin-potassium therapy for treatment of acute myocardial infarction.

Mamas MA, Neyses L, Fath-Ordoubadi F.

Exp Clin Cardiol. 2010 Summer;15(2):e20-4.

34.

Distal stent delivery with Guideliner catheter: first in man experience.

Mamas MA, Fath-Ordoubadi F, Fraser DG.

Catheter Cardiovasc Interv. 2010 Jul 1;76(1):102-11. doi: 10.1002/ccd.22458.

PMID:
20578090
35.

Resting Pd/Pa measured with intracoronary pressure wire strongly predicts fractional flow reserve.

Mamas MA, Horner S, Welch E, Ashworth A, Millington S, Fraser D, Fath-Ordoubadi F, Neyses L, El-Omar M.

J Invasive Cardiol. 2010 Jun;22(6):260-5.

PMID:
20516504
36.

Use of the sheathless guide catheter during routine transradial percutaneous coronary intervention: a feasibility study.

Mamas M, D'Souza S, Hendry C, Ali R, Iles-Smith H, Palmer K, El-Omar M, Fath-Ordoubadi F, Neyses L, Fraser DG.

Catheter Cardiovasc Interv. 2010 Mar 1;75(4):596-602. doi: 10.1002/ccd.22246.

PMID:
20049959
37.

Letter by Venetucci et al regarding article "Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial".

Venetucci L, Fath-ordoubadi F, Fraser D.

Circ Cardiovasc Interv. 2009 Dec;2(6):e5; author reply e6. doi: 10.1161/CIRCINTERVENTIONS.109.912196. No abstract available.

PMID:
20031762
38.

A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure.

Mamas MA, Caldwell JC, Chacko S, Garratt CJ, Fath-Ordoubadi F, Neyses L.

Eur J Heart Fail. 2009 Jul;11(7):676-83. doi: 10.1093/eurjhf/hfp085.

39.

Use of the Heartrail II catheter as a distal stent delivery device; an extended case series.

Mamas MA, Eichhöfer J, Hendry C, El-Omar M, Clarke B, Neyses L, Fath-Ordoubadi F, Fraser D.

EuroIntervention. 2009 Jun;5(2):265-71.

PMID:
19527983
40.

The role of thrombectomy and distal protection devices during percutaneous coronary interventions.

Mamas MA, Fraser D, Fath-Ordoubadi F.

EuroIntervention. 2008 May;4(1):115-23. Review.

PMID:
19112788
41.

Successful percutaneous closure of coronary artery fistula with angiographic follow-up at 6 months.

Hendry C, Mahadevan V, Fath-Ordoubadi F.

Catheter Cardiovasc Interv. 2009 Mar 1;73(4):581-3. doi: 10.1002/ccd.21830.

PMID:
19085916
42.

Atraumatic complex transradial intervention using large bore sheathless guide catheter.

Mamas MA, Fath-Ordoubadi F, Fraser DG.

Catheter Cardiovasc Interv. 2008 Sep 1;72(3):357-364. doi: 10.1002/ccd.21637.

PMID:
18727126
43.

Successful use of the Heartrail III catheter as a stent delivery catheter following failure of conventional techniques.

Mamas MA, Fath-Ordoubadi F, Fraser D.

Catheter Cardiovasc Interv. 2008 Feb 15;71(3):358-63. doi: 10.1002/ccd.21395.

PMID:
18288735
44.

Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial.

Chevalier B, Serruys PW, Silber S, Garcia E, Suryapranata H, Hauptmann K, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D.

EuroIntervention. 2007 Feb;2(4):426-34.

PMID:
19755281
45.

Drug-eluting stents for the treatment of in-stent restenosis--'real world' double centre experience in consecutive patients.

Anderson RA, Fath-Ordoubadi F, Younas S, Bainbridge A, Swallow RA, Dawkins KD, Curzen NP.

Int J Cardiovasc Intervent. 2005;7(4):188-92.

PMID:
16373265
46.

Adjunctive Antiplatelet / Antithrombotic therapy in percutaneous coronary intervention.

Eichhöfer J, Fraser D, Fath-Ordoubadi F.

EuroIntervention. 2005 Nov;1(3):352-7.

PMID:
19758929
47.
48.

Myocardial infarction after aspirin treatment.

Fox DJ, Gray TP, Fath-Ordoubadi F.

J R Soc Med. 2005 Jan;98(1):21-3. No abstract available.

49.

A novel method for the detection of transient myocardial ischaemia using body surface electrocardiac mapping.

Carley S, Mackway-Jones K, Jenkins M, Darlington E, Fath-Ordoubadi F, Curzen N.

Int J Cardiol. 2004 May;95(1):75-81.

PMID:
15159042
50.

Recurrent stent thrombosis associated with lupus anticoagulant due to renal cell carcinoma.

Muir DF, Stevens A, Napier-Hemy RO, Fath-Ordoubadi F, Curzen N.

Int J Cardiovasc Intervent. 2003;5(1):44-6.

PMID:
12623565

Supplemental Content

Loading ...
Support Center